Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma
Clinical trial NCT02583477 · COMPLETED
Trial details
- NCT number
- NCT02583477
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-25
- Primary completion
- 2018-07-09
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.